GlassScriptPhysician profile
Brian Edward Ng
NPI 1063935591
$2,350.08
in general payments reported to CMS, 2019-2025
17 companies · $84.00 in 2025
The $84.00 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $146 · 2021: $220 · 2022: $306 · 2023: $313 · 2024: $427 · 2025: $84.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $720.52 | 2019-2024 | Cequa |
| Alcon Vision LLC | $296.54 | 2019-2025 | Eysuvis, Total30, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $215.99 | 2019 | |
| Allergan, INC. | $204.37 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $163.70 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $158.86 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $150.62 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $120.51 | 2023-2025 | Miebo, Xiidra |
| Glaukos Corporation | $99.77 | 2022 | |
| Abbvie INC. | $59.10 | 2022-2024 | |
| Optos, INC. | $40.75 | 2019 | |
| Aerie Pharmaceuticals, INC. | $25.00 | 2019 | |
| Dompe US, INC. | $22.18 | 2022 | |
| Eyevance Pharmaceuticals LLC | $20.78 | 2020 | |
| Kala Pharmaceuticals, INC. | $17.45 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $16.99 | 2019 | |
| Shire North American Group INC | $16.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.